Serkan Bektur, MD
Advanced Heart Failure and Transplant Cardiology · Iowa City, IANPI 1902548928
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,743 of the $5,449 with a category attached, or 68.7%. 8 manufacturers reported payments, led by Abbott at 45.2% of the total. Reporting peaked in 2023 at $1,874 and has fallen 76.8% since, to $435 in 2025.
Across 47 payments — averaging $115.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Abiomed$2K
- Medtronic$892
- Impulse Dynamics (USA) Inc.$200
- Bayer$200
- Elutia, Inc.$80
- plus $98 from 2 others
What the payments were for
- Consulting fees$2004%
- Travel & lodging$3,74369%
- Food & beverage$1,50628%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $2,462 |
| Abiomed | 4 | $1,518 |
| Medtronic | 10 | $892 |
| Impulse Dynamics (USA) Inc. | 2 | $200 |
| Bayer | 1 | $200 |
| Elutia, Inc. | 1 | $80 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $53 |
| Edwards Lifesciences | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,444
- CARDIOMEMS$1,308
- ENSITE PRECISION$594
- OPTIMIZER$365
- Adempas$200
How this compares
Too few advanced heart failure and transplant cardiology providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 11 | $230,692 |
| JardianceEmpagliflozin | 84 | $82,567 |
| EntrestoSacubitril/Valsartan | 58 | $60,420 |
| EliquisApixaban | 33 | $37,818 |
| XareltoRivaroxaban | 13 | $16,802 |
| Bumetanide | 16 | $2,934 |
| Metoprolol Succinate | 196 | $2,416 |
| Potassium Chloride | 73 | $1,195 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 65 | $963 |
| Torsemide | 18 | $782 |
| Atorvastatin Calcium | 76 | $704 |
| Furosemide | 106 | $624 |
| Ezetimibe | 22 | $577 |
| Amiodarone Hcl | 11 | $574 |
| Spironolactone | 80 | $474 |
Paid to pharmacies, not to this prescriber.
Other advanced heart failure and transplant cardiology in Iowa City
- Linda CadaretIowa City$14K
- Pavida PachariyanonIowa City$11K
- Ernesto Ruiz DuqueIowa City$8K
- Paulino AlvarezIowa City$2K
- Alexandros BriasoulisIowa City$725
- Kelly Ann Light McGroaryIowa City$440
- Ily Kristine YumulIowa City$247
- Frances JohnsonIowa City$111
- Mansour EsmaeiliIowa City$26
- Akrivi ManolaDes Moines$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.